A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

计划入组 2 人 · 首次发布于 2008 年 11 月 24 日

SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome

计划入组 26 人 · 首次发布于 2022 年 4 月 1 日

GIP: Glucose-dependent Insulinotropic Peptide

计划入组 41 人 · 首次发布于 2005 年 10 月 17 日

ZP-I-98

Werner syndrome ATP dependent helicase inhibitor (cancer)

VLP-GIP

ALPORT SYNDROME FOUNDATION

United States

International Rett Syndrome Foundation

United States

RETT SYNDROME RESEARCH TRUST

United States

Vogenx raises $81.3M in Nasdaq IPO to advance SGLT1 inhibitor mizagliflozin in metabolic disorders

Clofutriben Shows Promise in Phase 2 Trial for Endogenous Cushing's Syndrome

FDA Expands Osilodrostat (Isturisa) Indication for Broader Cushing's Syndrome Treatment